These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38045440)

  • 1. Machine learning-based biomarker profile derived from 4210 serially measured proteins predicts clinical outcome of patients with heart failure.
    de Bakker M; Petersen TB; Rueten-Budde AJ; Akkerhuis KM; Umans VA; Brugts JJ; Germans T; Reinders MJT; Katsikis PD; van der Spek PJ; Ostroff R; She R; Lanfear D; Asselbergs FW; Boersma E; Rizopoulos D; Kardys I
    Eur Heart J Digit Health; 2023 Dec; 4(6):444-454. PubMed ID: 38045440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic personalized risk prediction in chronic heart failure patients: a longitudinal, clinical investigation of 92 biomarkers (Bio-SHiFT study).
    Klimczak-Tomaniak D; de Bakker M; Bouwens E; Akkerhuis KM; Baart S; Rizopoulos D; Mouthaan H; van Ramshorst J; Germans T; Constantinescu A; Manintveld O; Umans V; Boersma E; Kardys I
    Sci Rep; 2022 Feb; 12(1):2795. PubMed ID: 35181700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-based differences in cardiovascular proteomic profiles and their associations with adverse outcomes in patients with chronic heart failure.
    de Bakker M; Petersen TB; Akkerhuis KM; Harakalova M; Umans VA; Germans T; Caliskan K; Katsikis PD; van der Spek PJ; Suthahar N; de Boer RA; Rizopoulos D; Asselbergs FW; Boersma E; Kardys I
    Biol Sex Differ; 2023 May; 14(1):29. PubMed ID: 37198662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) heart failure risk score and the effect of adding natriuretic peptide for predicting mortality after discharge in hospitalized patients with heart failure.
    Khanam SS; Choi E; Son JW; Lee JW; Youn YJ; Yoon J; Lee SH; Kim JY; Ahn SG; Ahn MS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ; Yoo BS
    PLoS One; 2018; 13(11):e0206380. PubMed ID: 30485284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimarker Analysis of Serially Measured GDF-15, NT-proBNP, ST2, GAL-3, cTnI, Creatinine, and Prognosis in Acute Heart Failure.
    Gürgöze MT; van Vark LC; Baart SJ; Kardys I; Akkerhuis KM; Manintveld OC; Postmus D; Hillege HL; Lesman-Leegte I; Asselbergs FW; Brunner-la-Rocca HP; van den Bos EJ; Orsel JG; de Ridder SPJ; Pinto YM; Boersma E
    Circ Heart Fail; 2023 Jan; 16(1):e009526. PubMed ID: 36408685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HFrEF subphenotypes based on 4210 repeatedly measured circulating proteins are driven by different biological mechanisms.
    Petersen TB; de Bakker M; Asselbergs FW; Harakalova M; Akkerhuis KM; Brugts JJ; van Ramshorst J; Lumbers RT; Ostroff RM; Katsikis PD; van der Spek PJ; Umans VA; Boersma E; Rizopoulos D; Kardys I
    EBioMedicine; 2023 Jul; 93():104655. PubMed ID: 37327673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel biomarker-driven prognostic models to predict morbidity and mortality in chronic heart failure: the EMPEROR-Reduced trial.
    Pocock SJ; Ferreira JP; Gregson J; Anker SD; Butler J; Filippatos G; Gollop ND; Iwata T; Brueckmann M; Januzzi JL; Voors AA; Zannad F; Packer M
    Eur Heart J; 2021 Nov; 42(43):4455-4464. PubMed ID: 34423361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction.
    Okuyama R; Ishii J; Takahashi H; Kawai H; Muramatsu T; Harada M; Yamada A; Motoyama S; Matsui S; Naruse H; Sarai M; Hasegawa M; Watanabe E; Suzuki A; Hayashi M; Izawa H; Yuzawa Y; Ozaki Y
    Heart Vessels; 2017 Jul; 32(7):880-892. PubMed ID: 28154958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarker-driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR-Preserved trial.
    Pocock SJ; Ferreira JP; Packer M; Zannad F; Filippatos G; Kondo T; McMurray JJV; Solomon SD; Januzzi JL; Iwata T; Salsali A; Butler J; Anker SD
    Eur J Heart Fail; 2022 Oct; 24(10):1869-1878. PubMed ID: 35796209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Older Adults, "Malignant" Left Ventricular Hypertrophy, and Associated Cardiac-Specific Biomarker Phenotypes to Identify the Differential Risk of New-Onset Reduced Versus Preserved Ejection Fraction Heart Failure: CHS (Cardiovascular Health Study).
    Seliger SL; de Lemos J; Neeland IJ; Christenson R; Gottdiener J; Drazner MH; Berry J; Sorkin J; deFilippi C
    JACC Heart Fail; 2015 Jun; 3(6):445-455. PubMed ID: 25982111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Proteomic Profile Predicts Survival in Heart Failure With Reduced Ejection Fraction.
    Gui H; She R; Luzum J; Li J; Bryson TD; Pinto Y; Sabbah HN; Williams LK; Lanfear DE
    Circ Genom Precis Med; 2021 Jun; 14(3):e003140. PubMed ID: 33999650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction.
    Chan MM; Santhanakrishnan R; Chong JP; Chen Z; Tai BC; Liew OW; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong RC; Chai P; Low AF; Richards AM; Lam CS
    Eur J Heart Fail; 2016 Jan; 18(1):81-8. PubMed ID: 26497848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Biomarker Predictors of Expanded Heart Failure Outcomes in Patients With Type 2 Diabetes Mellitus After a Recent Acute Coronary Syndrome: Insights From the EXAMINE Trial.
    Sharma A; Vaduganathan M; Ferreira JP; Liu Y; Bakris GL; Cannon CP; White WB; Zannad F
    J Am Heart Assoc; 2020 Jan; 9(1):e012797. PubMed ID: 31902327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to N-Terminal Pro-B-Type Natriuretic Peptide: Insights From the DAPA-HF Trial.
    Butt JH; Adamson C; Docherty KF; de Boer RA; Petrie MC; Inzucchi SE; Kosiborod MN; Maria Langkilde A; Lindholm D; Martinez FA; Bengtsson O; Schou M; O'Meara E; Ponikowski P; Sabatine MS; Sjöstrand M; Solomon SD; Jhund PS; McMurray JJV; Køber L
    Circ Heart Fail; 2021 Dec; 14(12):e008837. PubMed ID: 34802253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimarker Strategy for Heart Failure Prognostication. Value of Neurohormonal Biomarkers: Neprilysin vs NT-proBNP.
    Bayes-Genis A; Barallat J; Galán A; de Antonio M; Domingo M; Zamora E; Gastelurrutia P; Vila J; Peñafiel J; Gálvez-Montón C; Lupón J
    Rev Esp Cardiol (Engl Ed); 2015 Dec; 68(12):1075-84. PubMed ID: 26297179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T.
    Emdin M; Aimo A; Vergaro G; Bayes-Genis A; Lupón J; Latini R; Meessen J; Anand IS; Cohn JN; Gravning J; Gullestad L; Broch K; Ueland T; Nymo SH; Brunner-La Rocca HP; de Boer RA; Gaggin HK; Ripoli A; Passino C; Januzzi JL
    J Am Coll Cardiol; 2018 Nov; 72(19):2309-2320. PubMed ID: 30384887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of temporal patterns of global longitudinal strain in patients with chronic heart failure.
    Abou Kamar S; Aga YS; de Bakker M; van den Berg VJ; Strachinaru M; Bowen D; Frowijn R; Akkerhuis KM; Brugts J; Manintveld O; Umans V; Geleijnse ML; Boersma E; van Dalen BM; Kardys I
    Front Cardiovasc Med; 2022; 9():1087596. PubMed ID: 36712255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex-specific cardiovascular protein levels and their link with clinical outcome in heart failure.
    de Bakker M; Loncq de Jong M; Petersen T; de Lange I; Akkerhuis KM; Umans VA; Rizopoulos D; Boersma E; Brugts JJ; Kardys I
    ESC Heart Fail; 2024 Feb; 11(1):594-600. PubMed ID: 38009274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction.
    Liu D; Hu K; Schregelmann L; Hammel C; Lengenfelder BD; Ertl G; Frantz S; Nordbeck P
    ESC Heart Fail; 2023 Apr; 10(2):1358-1371. PubMed ID: 36732921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation.
    Kristensen SL; Jhund PS; Mogensen UM; Rørth R; Abraham WT; Desai A; Dickstein K; Rouleau JL; Zile MR; Swedberg K; Packer M; Solomon SD; Køber L; McMurray JJV;
    Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29018174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.